Climb Bio Inc (CLYM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,897 | -65,481 | -56,586 | -1,697 | -35,119 |
| Depreciation Amortization | -757 | -232 | -63 | -63 | -2,331 |
| Accounts payable and accrued liabilities | -963 | -1,377 | -1,160 | 20 | -686 |
| Other Working Capital | 1,698 | 26 | 1,340 | -640 | 3,764 |
| Other Operating Activity | 58,357 | 57,023 | 53,983 | 561 | 13,773 |
| Operating Cash Flow | $-15,562 | $-10,041 | $-2,486 | $-1,819 | $-20,599 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -111,447 | -58,038 | 13,751 | 13,751 | 68,981 |
| Other Investing Activity | -9,645 | -9,645 | -9,645 | 0 | 0 |
| Investing Cash Flow | $-121,092 | $-67,683 | $4,106 | $13,751 | $68,981 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 130,729 | 130,688 | 128,417 | 15 | 841 |
| Financing Cash Flow | $130,729 | $130,688 | $128,417 | $15 | $841 |
| Exchange Rate Effect | 42 | 99 | -9 | -28 | 304 |
| Beginning Cash Position | 93,112 | 93,112 | 93,112 | 93,112 | 43,585 |
| End Cash Position | 87,229 | 146,175 | 223,140 | 105,031 | 93,112 |
| Net Cash Flow | $-5,883 | $53,063 | $130,028 | $11,919 | $49,527 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,562 | -10,041 | -2,486 | -1,819 | -20,599 |
| Free Cash Flow | -15,562 | -10,041 | -2,486 | -1,819 | -20,599 |